Overview

Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis

Status:
Completed
Trial end date:
2021-04-15
Target enrollment:
Participant gender:
Summary
This study is aimed at assessing the efficacy of Apraclonidine eye drops in the treatment of ptosis secondary to myasthenia gravis.
Phase:
Phase 2
Details
Lead Sponsor:
American University of Beirut Medical Center
Treatments:
Apraclonidine